Stocks · Health care · Pharmaceutical Preparations

Tango Therapeutics, Inc.

TNGX Clue Score51
United States Fiscal year ends December CIK 0001819133 Results filed 11 Aug 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Adam Crystal
2 Nov 2026
President, R&D
Sold after exercise
1,100
$22.99
$25.29K
Adam Crystal
2 Nov 2026
President, R&D
Sold after exercise
3,900
$22.26
$86.82K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 5,000
History held since 10 Sep 2020